Medicated Skin Care in South Korea
Euromonitor International's Medicated Skin Care in South Korea market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 40 | Publication date: Feb 2008
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
OTC HEALTHCARE IN SOUTH KOREA : MARKET INSIGHT
EXECUTIVE SUMMARY
Slowdown in 2006
Increasing health concerns drive sales growth
Vitamins and dietary supplements remains the largest product group
Rapid growth of Rx industry hinders the growth of OTC
Moderate forecast value growth is expected
KEY TREND AND DEVELOPMENTS
Rx continues to record faster growth than OTC
Wellbeing trend leads to positive sales growth of OTC healthcare
Established brands consolidate their positions
Declining birth rate affects demand for child-specific OTC healthcare
Growing importance of retail grocery channels
Growing number of entries leads to fragmentation
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 7 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 8 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 9 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 10 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - SOUTH KOREA
DAEWOONG PHARMACEUTICAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Daewoong Pharmaceutical Co Ltd: Key Facts
Summary 3 Daewoong Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Daewoong Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 5 Daewoong Pharmaceutical Co Ltd: Competitive Position 2006
DONG WHA PHARMACEUTICAL INDUSTRIAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
STRATEGIC DIRECTION
KEY FACTS
Summary 6 Dong Wha Pharmaceutical Ind. Co Ltd: Key Facts
Summary 7 Dong Wha Pharmaceutical Ind. Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 8 Dong Wha Pharmaceutical Ind. Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 9 Dong Wha Pharmaceutical Ind. Co Ltd: Competitive Position 2006
DONG-A PHARMACEUTICAL CO LTD - OTC HEALTHCARE - SOUTH KOREA
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Dong-A Pharmaceutical Co Ltd: Key Facts
Summary 11 Dong-A Pharmaceutical Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 12 Dong-A Pharmaceutical Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 13 Dong-A Pharmaceutical Co Ltd: Competitive Position 2006
KOREA GINSENG CORP - OTC HEALTHCARE - SOUTH KOREA
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Korea Ginseng Corp: Key Facts
Summary 15 Korea Ginseng Corp: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 16 Korea Ginseng Corp: Production Statistics
COMPETITIVE POSITIONING
Summary 17 Korea Ginseng Corp: Competitive Position 2006
SK CHEMICALS CO LTD - OTC HEALTHCARE - SOUTH KOREA
STRATEGIC DIRECTION
KEY FACTS
Summary 18 SK Chemicals Co Ltd: Key Facts
Summary 19 SK Chemicals: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 20 SK Chemicals Co Ltd: Production Statistics
COMPETITIVE POSITIONING
Summary 21 SK Chemicals Co Ltd: Competitive Position 2006
MEDICATED SKIN CARE IN SOUTH KOREA
HEADLINES
TREND
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 12 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 13 Herbal vs Standard Medicated Skin Care 2001/2006
Table 14 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 15 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 16 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 17 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 18 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 19 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011